Stay updated on Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial
Sign up to get notified when there's something new on the Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial page.

Latest updates to the Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedAdded Revision: v3.4.2 and removed the funding-notice block along with the prior Revision: v3.4.1 entry.SummaryDifference0.8%

- Check26 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and the NIH Clinical Center's operating status, and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check33 days agoChange DetectedThe update consists of UI/formatting changes to the history view (glossary toggle label, color-coded highlights, and revision labels). These changes do not affect study data or content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1.0%

- Check48 days agoChange DetectedAdded Revision: v3.3.4 to the Record History. Removed Revision: v3.3.3 from the Record History.SummaryDifference0.1%

- Check69 days agoChange DetectedAdded a new Revision: v3.3.3 to the record history; removed the HHS Vulnerability Disclosure link and Revision: v3.3.2 from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check91 days agoChange DetectedThe Record History now includes a new revision entry (v3.3.2) and the previous revision (v3.3.1) has been removed. This change only affects version tracking rather than any study data, results, or core page content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial page.